patient view
This page is a research summary built from public sources (FDA, NIH, clinical trial registries). It is not medical advice.Always talk to your doctor about treatment decisions. Drug information here may be incomplete or out of date — verify with your prescriber and the manufacturer's package insert.
drug · vaccine component
meningococcal [serotype B] vaccine
Phase 3updated 2mo agoby $GSK GSK plc🔗 ChEMBL
Phase 3community read0 votes
Vaccine component drug with a maximum clinical stage of Approval (across all indications), with an approval for meningococcal infection and meningococcal meningitis.
targets
Neisserial heparin binding antigen
all catalysts(0)
nothing on the calendar yet
News(0)
no news has mentioned this drug yet
comments(0)
5-min edit window · permanent after that